Presents a refreshing new approach to issues surrounding the development, regulation and supply of medicinal drugs to the consumer. The book draws together the role of government, industry, doctors and pharmacists in determining drug accessibility and cost, and details their impact on consumers. It highlights many problems and suggests ways of improving the system so it is more equitable and humane.